The evidence on indications, outcomes, and complications with the use of extracorporeal
membrane oxygenation (ECMO) in the setting of interstitial lung disease (ILD) is limited in …

© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016; 8 (8): 1918-1920 jtd.
amegroups. com patient improved, 4 died before being fully evaluated and 1 was ineligible …

Rationale: Patients with interstitial lung disease and acute respiratory failure have a poor
prognosis especially if mechanical ventilation is required. Objectives: To investigate the …

Background Whether acute respiratory failure in patients with interstitial lung disease is
reversible remains uncertain. Consequently, indications for extracorporeal membrane …

Backgrounds: Acute exacerbation of interstitial lung diseases (AE-ILD) is a fatal disease of
unknown etiology. No treatments have proven to be curative for AE-ILD. Aims: To investigate …

Background Extracorporeal membrane oxygenation (ECMO) as a bridge to lung
transplantation for end-stage interstitial lung disease (ILD) and pulmonary hypertension …

Background Despite limited organ availability, extracorporeal membrane oxygenation
(ECMO) and retransplantation are becoming more commonplace. Methods Using the United …

Purpose To assess the outcomes of Extracorporeal Membrane Oxygenation (ECMO) as a
bridge to lung transplantation (BTT) with intent to treat. Methods Retrospective data was …

Extracorporeal membrane oxygenation (ECMO) is rarely used as a bridge to lung
transplantation (BTT) because of its associated morbidity and mortality. However, recent …

Interstitial lung disease (ILD) represents a collection of lung disorders with a lethal trajectory
with few therapeutic options with the exception of lung transplantation. Various …